Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Pharma Biotech M a Transactions 2005-2012

Pharma Biotech M a Transactions 2005-2012

Ratings: (0)|Views: 28 |Likes:
Published by Aniket Apte

More info:

Published by: Aniket Apte on Apr 17, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as XLSX, PDF, TXT or read online from Scribd
See more
See less

11/27/2013

pdf

text

original

 
HBM Pharma/Biotech M+A Report - List of Transactions Since 2005
Information on "VC/PE-Investment", "Clinical Stage" and "Therapeutic Area" only complete for VC/PE-backed companies
 YearTarget companyCountryPublic /privateVC/PEBuyerCountryUpfront DealValue ($m)Total DealValue ($m)VC/PE Invest-ment ($m)Cash / sharesClinical Stage of Lead ProductTherapeutic Area(s) of Target Company
2005 Hexal Pharma (Eon Labs) G Private Novartis CH 8300 8300 - Cash Generics2005 Abgenix US Public Amgen US 2600 2600 33 Cash2005 Vicuron US Public Pfizer US 1900 1900 - -2005 Transkaryotic Therapies US Public Shire UK 1600 1600 57 -2005 Fournier Pharma F Private Solvay B 1440 1938 - Cash Metabolic, cardiovascula2005 ID Biomedical US Public GSK UK 1400 1400 - Cash Vaccines2005 Eyetech US Public OSI US 935 935 142 -2005 Agis Industries Israel Public Perrigo US 818 818 - Cash & shares Various2005 Viatris G PrivatePEMeda S 738 738 - Cash Market Respiratory, pain2005 Bone Care US Public Genzyme US 600 600 - -2005 Berna Biotech CH Public Crucell NL 446 446 - Shares Vaccines2005 ESP Pharma US PrivateVCProtein Design Labs US 379 379 60 Cash & shares Market Cardiovascular, various2005 Zeneus UK PrivatePECephalon US 360 360 80 Cash Market Oncology2005 Corixa US Public GSK UK 301 301 20 - Vaccines2005 FEI Women's Health US Private Duramed/Barr US 282 282 - Cash Women's health2005 Idun Pharmaceuticals US PrivateVCPfizer US 280 280 100 Cash 2 Anti-infectives2005 Xcel Pharmaceuticals US PrivatePEValeant Canada 280 280 88 Cash Market CNS2005 Syrrx US PrivateVCTakeda J 275 275 135 Cash 1 Metabolic, various2005 Docpharma B Private Matrix Laboratories India 263 263 - Cash Various2005 Peninsula US PrivateVCJohnson & Johnson US 245 245 93 Cash 3 Anti-infectives2005 TransForm Pharmaceuticals US PrivateVCJohnson & Johnson US 230 230 80 Cash 22005 AaiPharma US Public Xanodyne Pharmaceuticals US 209 209 - - Services2005 InKine US Public Salix US 190 190 - Shares GI2005 Arakis UK PrivateVCSosei J 186 186 90 Cash & shares 2 Respiratory, inflammation, pain2005 Glycart CH PrivateVCRoche CH 181 181 20 Cash Pre-clinical2005 Guilford Pharmaceuticals US Public MGI Pharma US 178 212 - Cash & shares2005 Salmedix US PrivateVCCephalon US 160 200 82 Cash 2 Oncology2005 Orphan Medical US Public Jazz Pharmaceuticals US 122 140 - -2005 Control Delivery Systems US PrivateVCpSividia Aus 104 104 34 Shares Market Ophtalmology, drug delivery2005 Neopharma S PrivateVCSolvay B 93 93 10 Cash Approval pend CNS2005 Igeneon A PrivateVCAphton US 81 81 68 Shares 3 Oncology2005 Bioren US PrivateVCPfizer US 80 80 - Cash Pre-clinical Various2005 Evotec Neurosciences CH PrivateVCEvotec G 54 54 28 Shares Pre-clinical CNS2005 Lorantis UK PrivateVCCelldex US 53 53 80 Shares Pre-clinical Autoimmune2005 Xenova UK Public Celtic Pharma Development UK 47 47 - Cash Oncology, various2005 Cellective Therapeutics US PrivateVCMedImmune US 40 160 26 Cash Pre-clinical Oncology, autoimmune2005 Aerogen US Public Nektar Therapeutics US 32 32 54 Cash & shares2005 Cita NeuroPharmaceuticals Canada Private Vernalis UK 30 65 - Cash CNS2005 Alteris US Private Celldex US 25 25 - Cash & shares Oncology2005 Ionix Pharmaceuticals UK PrivateVCVernalis UK 22 30 42 Shares n.a. Pain, CNS2005 Afmedica US PrivateVCAngiotech US 22 22 3 Cash n.a. Various2005 Aptamera US PrivateVCAntisoma UK 21 21 - Shares 1 Oncology2005 ActivX Biosciences US PrivateVCKyorin J 21 21 39 Cash Pre-clinical Various2005 Greenwich Therapeutics US Private VioQuest US 20 20 - Shares Oncology2005 Angiosyn US PrivateVCPfizer US 15 527 2 Cash Pre-clinical Ophtalmology2005 Cambridge Biotechnology UK PrivateVCBiovitrum S 14 14 20 Cash Pre-clinical Pain
HBM Partners AG / July 2012Page 1
 
HBM Pharma/Biotech M+A Report - List of Transactions Since 2005
Information on "VC/PE-Investment", "Clinical Stage" and "Therapeutic Area" only complete for VC/PE-backed companies
 YearTarget companyCountryPublic /privateVC/PEBuyerCountryUpfront DealValue ($m)Total DealValue ($m)VC/PE Invest-ment ($m)Cash / sharesClinical Stage of Lead ProductTherapeutic Area(s) of Target Company
2005 Survac DK PrivateVCMerck KGaA G 13 13 1 Cash Pre-clinical Oncology2005 Sirenade G PrivateVCKeyNeurotek G 9 9 11 Cash 1 CNS2005 Trinity Labs US Private Jubilant Organosys India 8 8 - Cash Various2005 GemVax S Private Pharmexa DK 5 10 - - Oncology2005 Delex Therapeutics Canada PrivateVCYM BioSciences Canada 5 20 - Cash 2 Oncology2005 Targeted Molecules US Private Chromos Canada 4 4 - Shares2005 Bioxalis Medica Canada Private Ambrilia Canada 4 4 - Cash Oncology2005 APS Pharma G Private ProStrakan UK 3 3 - Cash2005 Inovio Norway Private Genetronics US 3 10 - Cash & shares Anti-infectives2005 Auvation UK Private EiRx UK 3 3 - Shares Oncology2005 Echelon US Private Aeterna Zentaris Canada 3 6 - Shares Oncology2005 Nurel Therapeutics US PrivateVCDiamyd Medical S 2 2 - Shares Pre-clinical Pain, metabolic2005 SansRosa US PrivateVCCollaGenex US 1 4 1 Cash Pre-clinical Dermatology2005 Artesian Therapeutics US PrivateVCCardiome Pharma Canada 64 12 Cash n.a. Cardiovascula2005 Allerbio F Private ALK-Abello DK - -2005 Amedis Pharmaceuticals UK Private Paradigm Therapeutics UK - -2005 Celogos F Private HR Pharma SA F - -2005 Eukarion US Private Proteome Systems Aus - - Various2005 G2M Cancer Drugs G PrivateVCTopoTarget DK 7 Shares Pre-clinical Oncology2005 Hematech US Private Kirin J - -2005 Hormos Medical Fin Private Quatrx US - - Women's health2005 IBFB Pharma G PrivateVCCuracyte G 10 - 3 Various2005 Metagen US Private Esprit Pharma US - Cash Urology2005 Metaphore US PrivateVCActivBiotics US 93 Shares Pre-clinical2005 Microscience UK PrivateVCEmergent BioSolutions US 80 Shares 2 Anti-infectives2005 Morphochem G PrivateVCBiovertis A 80 Shares n.a. Anti-infectives2005 Psychenomics US Private Novasite US - - CNS2005 WE Pharmaceuticals US Private airPharma US - -2006 Schering AG G Public Bayer G 21500 21500 - Cash Various2006 Serono CH Public Merck KGaA G 13500 13500 - Cash Various2006 Ivax US Public Teva Israel 7400 7400 - Cash & shares Generics2006 Schwarz Pharma G Public UCB B 5700 5700 - Cash Cardiovascular, GI, CNS2006 Altana Pharma G Public Nycomed DK 5345 5345 - Cash & shares2006 Chiron US Public Novartis CH 5100 5100 - Cash2006 KOS US Public Abbott Laboratories US 3700 3700 - Cash Cardiovascula2006 Myogen US Public Gilead Sciences US 2500 2500 132 - Cardiovascula2006 Pliva Croatia Public Barr Pharmaceuticals US 2500 2500 - Cash Generics2006 ICOS US Public Eli Lilly US 2300 2300 33 Cash Erectile dysfunction2006 Andrx US Public Watson Pharmaceuticals US 1900 1900 - Cash Various2006 Sirna (Ribozyme) US Public Merck & Co US 1100 1100 40 Cash Ophalmology2006 Cambridge Antibody Technology UK Public AstraZeneca UK 1070 1070 - Cash2006 Tanox US Public Genentech US 922 922 55 -2006 AnorMed US Public Genzyme US 580 580 25 Cash Oncology2006 Betapharm G PrivatePEDr Reddy India 570 570 150 Cash Market Generics2006 NeuTec Pharma UK Public Novartis CH 566 566 14 Cash2006 Domantis UK PrivateVCGSK UK 454 454 83 Cash Pre-clinical Various
HBM Partners AG / July 2012Page 2
 
HBM Pharma/Biotech M+A Report - List of Transactions Since 2005
Information on "VC/PE-Investment", "Clinical Stage" and "Therapeutic Area" only complete for VC/PE-backed companies
 YearTarget companyCountryPublic /privateVC/PEBuyerCountryUpfront DealValue ($m)Total DealValue ($m)VC/PE Invest-ment ($m)Cash / sharesClinical Stage of Lead ProductTherapeutic Area(s) of Target Company
2006 Corus Pharma US PrivateVCGilead Sciences US 420 420 150 Cash 3 Respiratory2006 Cotherix US Public Actelion CH 417 417 67 Cash Cardiovascula2006 GlycoFi US PrivateVCMerck & Co US 400 400 40 Cash Pre-clinical Various2006 Rinat Neuroscience US PrivateVCPfizer US 400 400 80 Cash 2 CNS2006 PowderMed UK PrivateVCPfizer US 300 400 45 Cash 2 Vaccines2006 Avidia US PrivateVCAmgen US 290 380 80 Cash 1 Autoimmune2006 Innovata UK Public Vectura UK 234 234 - Shares Respiratory2006 Fumapharm CH Private Biogen Idec US 230 500 - Cash CNS2006 Kudos UK PrivateVCAstraZeneca UK 210 210 80 Cash 1 Oncology2006 Conforma US PrivateVCBiogen Idec US 150 250 60 Cash 1 Oncology2006 Pinewood Ireland Private Wockhardt India 150 150 - Cash Various2006 Valera US Public Indevus US 120 120 35 Shares Oncology, urology2006 Douglas Laboratories Canada Private Atrium Canada 100 100 - Shares Various2006 Novosis G Private Schweizerhall CH 82 98 - Cash & shares Various2006 Abmaxis US PrivateVCMerck & Co US 80 80 10 Cash Pre-clinical Drug discovery2006 Avidex UK PrivateVCMediGene G 62 62 72 Shares 1 Autoimmune, RA2006 Cabrellis Pharmaceuticals Corpo US PrivateVCPharmion US 59 59 34 Cash 2 Oncology2006 Jaba Pharmaceutica Portugal Private Recordati Italy 57 57 - Cash Various2006 SBL Vaccine AB S PrivateVCCrucell NL 50 50 - Cash Market Vaccines2006 Cellpep F PrivateVCProcyon Canada 39 39 15 Shares Approval pend Oncology2006 Carlsson Research S PrivateVCNeuroSearch DK 33 122 20 Cash Pre-clinical CNS2006 Eximias US PrivateVCYM BioSciences Canada 29 29 95 Cash & shares 3 Oncology2006 MarcoMed US Private Protherics US 25 25 - Shares Oncology2006 Sirius US Private DUSA Pharmaecuticals US 22 30 - Cash & shares Dermatology2006 Miikana US PrivateVCEntreMed US 21 21 8 Shares 1 Oncology2006 RXKinetix US PrivateVCEndo Pharmaceuticals US 20 115 35 Cash 2 Oncology2006 Montigen US Private SuperGen US 18 40 - Cash & shares Oncology2006 DnAge NL PrivateVCPharming NL 18 18 3 Shares Pre-clinical Metabolic, CNS2006 Vela Pharmaceuticals US PrivateVCPharmos US 18 18 60 Cash & shares 2 Autoimmune2006 Saegis US PrivateVCLundbeck DK 14 15 51 Cash 2 CNS2006 Haptoguard US Private Synvista (former Alteon) US 9 9 - Shares Cardiovascula2006 AirPharma US Private Meldex UK 8 8 - Cash & shares2006 Urdur Iceland Private DeCode Genetics Iceland 6 6 - Shares Oncology2006 Nobex US PrivateVCBiocon India 5 5 81 Cash 2 Metabolic2006 Alamo Pharmaceuticals US Private Avanir Pharmaceuticals US 4 29 - Cash CNS2006 ProlX US Private Biomira Canada 3 18 - Cash & shares Oncology2006 Segix Pharma Italy Private Mendex (former Bioprogess) UK 2 2 - Cash & shares2006 Cutanogen US Private Cambrex US 2 6 - Cash Wound care2006 TheraPei Pharmaceuticals US Private Forbes Medi-Tech Canada 1 50 - Cash & shares Metabolic2006 MNL Pharma UK PrivateVCSummit UK 1 1 - Cash Pre-clinical Oncology2006 IviGene US Private Oragenics US - Shares Various2006 Sciencom UK Private Regen Therapeutics UK - Cash CNS2006 4AZA B Private Elbion G - Shares2006 Athelas CH PrivateVCMerlion Singapore - Shares Pre-clinical Anti-infectives2006 Bittner Pharma Group A Private Omega Pharma B - - Various2006 CareX F PrivateVC7TM DK 36 - Pre-clinical Metabolic
HBM Partners AG / July 2012Page 3

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->